NSF included in the labelling for gadolinium-based contrast agents

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gadolinium-containing contrast agents linked to NSF

Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Gadolinium-containing contrast agents linked to NSF

Inpharma, Vol. 1, Iss. 1575, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Gadolinium-containing contrast agents and NSF - update

Reactions Weekly, Vol. 1, Iss. 1159, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

FDA alerts to safety issues with gadolinium-based contrast agents

Reactions Weekly, Vol. 1, Iss. 1134, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature

By Raisch Dennis W Garg Vishvas Arabyat Rasha Shen Xian Edwards Beatrice J Miller Frank H McKoy June M Nardone Beatrice West Dennis P

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite